Marc-Oliver Grimm

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Combination Therapy

Epithelial Mesenchymal Transition

Metastatic Renal Cell Carcinoma

Top Venues

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) 20 (19) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) (2024)
Klara Franke, Susan Foller, Michele Estephania Rosero Moreno, Nalyan Ali, Lutz Leistritz, Katharina Leucht, Marc-Oliver Grimm
Reasonability of Frequent Laboratory Analyses during Therapy with Nivolumab and Nivolumab+Ipilimumab in Patients with Advanced or Metastatic Renal Cell Carcinoma during the Phase 2 Clinical Trial TITAN-RCC. Cancers 16 (12) (2024)
Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C Goh, Cristina Suarez, Christian K Kollmannsberger, Suresh G Nair, Brian M Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, Viktor Gruenwald
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data. Journal of medical economics 27 (1) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data. Journal of medical economics 27 (1) (2024)
Klara Franke, Susan Foller, Michele Estephania Rosero Moreno, Nalyan Ali, Lutz Leistritz, Katharina Leucht, Marc-Oliver Grimm
Reasonability of Frequent Laboratory Analyses during Therapy with Nivolumab and Nivolumab+Ipilimumab in Patients with Advanced or Metastatic Renal Cell Carcinoma during the Phase 2 Clinical Trial TITAN-RCC. Cancers 16 (12) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) 20 (19) (2024)
Guenter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Silke Guenther, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis. Future oncology (London, England) 20 (19) (2024)
Fei Song, Qingqing Dai, Marc-Oliver Grimm, Daniel Steinbach
The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers. Cancers 15 (4) (2023)
Fei Song, Qingqing Dai, Marc-Oliver Grimm, Daniel Steinbach
The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers. Cancers 15 (4) (2023)
Fei Song, Qingqing Dai, Marc-Oliver Grimm, Daniel Steinbach
The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers. Cancers 15 (4) (2023)
Daniel Wegener, Daniel Matthias Aebersold, Marc-Oliver Grimm, Peter Hammerer, Michael Froehner, Markus Graefen, Dirk Boehmer, Daniel Zips, Thomas Wiegel
Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage. Biomedicines 10 (9) (2022)
Marc-Oliver Grimm, Bernd Jürgen Schmitz-Dräger, Uwe Zimmermann, Christine Barbara Grün, Gustavo Bruno Baretton, Marc Schmitz, Susan Foller, Katharina Leucht, Martin Schostak, Friedemann Zengerling, Ulrike Schumacher, Wolfgang Loidl, Johannes Meran
Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Katharina Leucht, Nalyan Ali, Susan Foller, Marc-Oliver Grimm
Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma. Cancers 14 (18) (2022)
Benjamin Giszas, Michael Fritzenwanger, Marc-Oliver Grimm, Andreas Stallmach, Philipp Alexander Reuken
Recurrent Disseminated Intravascular Coagulation in Metastatic Castration-Resistant Prostate Cancer: A Case Report. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Fei Song, Roland Kotolloshi, Mieczyslaw Gajda, Martin Hölzer, Marc-Oliver Grimm, Daniel Steinbach
Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines. International journal of molecular sciences 23 (21) (2022)
Roland Kotolloshi, Mieczyslaw Gajda, Marc-Oliver Grimm, Daniel Steinbach
Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells. International journal of molecular sciences 23 (10) (2022)
Sophie Bartsch, Kimia Mirzakhani, Laura Neubert, Alexander T Stenzel, Marzieh Ehsani, Mohsen Esmaeili, Thanakorn Pungsrinont, Merve Kacal, Seyed Mohammad Mahdi Rasa, Julia Kallenbach, Divya Damodaran, Federico Ribaudo, Marc-Oliver Grimm, Francesco Neri, Aria Baniahmad
Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors. Cancers 13 (16) (2021)
Marc-Oliver Grimm, Katharina Leucht, Susan Foller
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma. Journal of clinical medicine 10 (22) (2021)
Philip Zeuschner, Sebastian Hölters, Michael Stöckle, Barbara Seliger, Anja Mueller, Hagen S Bachmann, Viktor Grünwald, Daniel C Christoph, Arnulf Stenzl, Marc-Oliver Grimm, Fabian Brüning, Peter J Goebell, Marinela Augustin, Frederik Roos, Johanna Harde, Iris Benz-Rüd, Michael D Staehler, Kerstin Junker
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study). Cancers 13 (11) (2021)
Roland Kotolloshi, Martin Hölzer, Mieczyslaw Gajda, Marc-Oliver Grimm, Daniel Steinbach
SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells. Cells 10 (1) (2021)